Transfers of Value: The One Concept Italian Life Sciences Companies Cannot Afford to Get Wrong

Many Italian life sciences companies are focusing heavily on technical preparation — XML files, portal access, and submission deadlines — while the real complexity often sits upstream.

It is called the transfer of value, and getting it right is one of the most important foundations of Italian Sunshine Reporting.

Italian Sunshine Reporting, governed by Law No. 62 of 31 May 2022, known as the Italian Sunshine Act, requires in-scope companies to disclose reportable transfers of value and certain relationships involving healthcare professionals and healthcare organisations. These disclosures will be made through the Ministry of Health’s Sanità Trasparente register and are expected to be publicly accessible for at least five years.

The law sets clear thresholds for transfers of value: individual transfers to an HCP exceeding €100, or annual totals exceeding €1,000, are reportable. For HCOs, individual transfers exceeding €1,000, or annual totals exceeding €2,500, are in scope. The law also covers certain agreements, participation in conferences or training events, advisory and scientific bodies, consultancy, teaching and research relationships, as well as certain ownership interests and payments linked to intellectual or industrial property rights.

And yet, many compliance teams continue to underestimate the conceptual groundwork required before reporting can happen accurately.

The Real Question Is Not Only How to Report — It Is Also What to Report

Many companies can describe the reporting mechanics fluently. They know about XML files, the Sanità Trasparente register, and the expected submission process. What they may not have done, in many cases, is sit down department by department and systematically map every flow of value that touches an HCP or HCO.

This is the transfer of value inventory, and it is one of the most consequential steps in the Italian Sunshine compliance journey. The question is not only “How do we submit our data?” It is also “Do we know what data we have?”

A medical education grant processed through a third-party events agency. A speaking honorarium routed through a different business unit. A meal reimbursement recorded in Concur under a non-standard cost centre. Each of these may represent a reportable transfer or relationship, depending on the recipient, value, structure, and applicable threshold. In many companies, no single person has visibility across all of them.

Why Companies Underestimate This Step

The transfer of value concept sounds intuitive until an organisation actually tries to inventory it.

The Italian Sunshine Act is broad. It captures transfers of money, goods, services, or other benefits, along with certain agreements involving participation in conferences, training events, committees, commissions, advisory bodies, scientific committees, consultancy, teaching, research relationships, ownership interests, and intellectual property-related payments.

Although the law identifies broad reportable categories, practical classification questions can still arise, especially where benefits are indirect, routed through intermediaries, or recorded inconsistently across systems.

For smaller companies and micro-enterprises, the challenge may be compounded by the absence of a dedicated compliance function. TOV data may be tracked across different software systems, in different formats, under different field naming conventions. One system may call it “codice fiscale,” another “VAT number,” and another “fiscal code.” Without a structured mapping exercise, discrepancies can become reporting errors, and reporting errors can become compliance risk.

What Good TOV Preparation Actually Looks Like

A robust transfer of value inventory should be conducted function by function — marketing, medical affairs, scientific affairs, commercial, finance, procurement, HR, events, clinical, and external agencies where relevant.

The exercise should identify both the nature of each transfer and the source system in which it is tracked. The output should be a detailed inventory document that becomes the foundation for data gap analysis, system configuration, validation, and eventual submission through the Sanità Trasparente register once the reporting framework becomes operational.

Even large, well-resourced companies may benefit from external review of their inventories — not because they lack competence, but because the exercise often surfaces questions that require both regulatory knowledge and operational experience to resolve correctly.

The transfer of value concept is not a technicality. It is the conceptual core of Italian Sunshine Reporting, and companies that master it early will find every downstream stage of compliance significantly easier.

If you are still uncertain about the scope of your reporting obligations, or simply want to hear how experts are approaching this question across the Italian market, the events and workshops offered by the Italian Sunshine Reporting community are a practical next step.

→ Explore upcoming events and webinars on Italian Sunshine Reporting